Peritoneal dialysis (PD) is a core modality of renal replacement therapy within nephrology. It operates on the physiological principles of diffusion and osmosis across the semipermeable peritoneal membrane. By instilling a hypertonic dialysate solution into the peritoneal cavity, excess fluid, urea, creatinine, and electrolytes shift from the rich blood vessel network of the abdominal wall and organs into the dialysate fluid. After a specified dwell time, the saturated fluid—termed effluent—is drained from the abdomen and replaced with fresh solution.

Unlike intermittent hemodialysis, which typically takes place three times per week in a clinical clinic setting, peritoneal dialysis is usually performed daily by the patient or a trained caregiver at home. It exists in two primary operational modalities: Continuous Ambulatory Peritoneal Dialysis (CAPD), which relies on manual fluid exchanges throughout the day, and Automated Peritoneal Dialysis (APD), which utilizes a mechanical cycler machine to perform exchanges while the patient sleeps. Clinical guidelines from the International Society for Peritoneal Dialysis (ISPD 2020) emphasize high-quality, goal-directed PD individualized to preserve residual kidney function and optimize quality of life.

Peritoneal dialysis therapy begins with the surgical placement of a Tenckhoff catheter into the peritoneal cavity under local or general anesthesia. After a healing window of 2 to 4 weeks, dialysis administration begins. The procedure comprises repetitive cycles known as exchanges, consisting of three distinct steps: Drain, Fill, and Dwell.

During the Drain phase, the patient connects their catheter to a sterile tubing system using strict aseptic technique. Gravitational flow or machine suction drains the accumulated effluent fluid from the abdominal cavity over 15 to 20 minutes. The drained fluid is visually checked for clarity.

During the Fill phase, fresh sterile dialysate solution (typically 1.5 to 2.5 liters) is infused into the peritoneal cavity through gravity or a cycler pump over 10 to 15 minutes. The solution volume is adjusted based on body surface area and abdominal tolerance.

During the Dwell phase, the catheter is clamped and capped. The solution remains inside the abdominal cavity for a prescribed duration—ranging from 1 to 3 hours in automated nocturnal protocols to 4 to 8 hours in continuous manual daytime protocols. During dwell time, metabolic waste diffuses across the peritoneal membrane into the dialysate, and osmotic agents pull excess fluid into the cavity. Once the dwell time completes, the cycle repeats.

Evidence-Based Clinical Benefits of Peritoneal Dialysis

Clinical registries and comparative outcome studies demonstrate several physiological and operational advantages of peritoneal dialysis compared to conventional hemodialysis:

• Preservation of Residual Kidney Function: Comparative observational trials demonstrate that peritoneal dialysis preserves residual urinary volume and nephron clearance longer than intermittent hemodialysis, which is linked to improved survival and fluid balance (NICE NG107 guidelines).
• Hemodynamic Stability: Because fluid removal occurs slowly and continuously over 24 hours rather than rapidly over 4 hours, PD avoids the sudden blood pressure drops (intradialytic hypotension) common in hemodialysis, reducing cardiac ischemic stress.
• Vascular Access Preservation: Eliminates the need for repeated needle sticks, arteriovenous (AV) fistulas, or central venous catheters, preserving native arm veins for future use.
• Lifestyle Flexibility and Autonomy: Home-based administration removes the requirement for tri-weekly clinic visits, permitting normal employment, travel, and personal scheduling.
• Needle-Free Administration: Fluid exchanges utilize the pre-established silicone catheter access, eliminating procedural needle pain.
• Better Initial Survival Rates: Multi-center cohort analyses show equivalent or slightly superior survival rates for peritoneal dialysis during the first 1 to 2 years of therapy initiation compared to standard center hemodialysis (KDIGO 2024 update).

Catheter Healing, Protocol Transition, and Long-Term Adaptation

Recovery in peritoneal dialysis involves two key dimensions: physical healing following surgical catheter insertion and lifestyle adaptation to routine home exchanges.

Immediate Post-Surgical Healing (Weeks 1–2)

Following surgical catheter placement, the primary goal is tissue healing around the dacron cuffs embedded in the abdominal wall. Minimal or flush exchanges are performed to prevent catheter clogging with fibrin, but full volume dialysis is deferred for 14 to 21 days whenever feasible. This waiting period significantly reduces the risk of pericatheter fluid leaks (ISPD 2022 Guidelines).

Prescription Titration and Training Phase (Weeks 3–4)

Once healed, the patient completes dedicated one-on-one training with a specialized nephrology nurse. Training covers aseptic technique, exit-site hygiene, fluid balance calculation, exchange mechanics, and cycler troubleshooting. Dialysis volume is gradually titrated from 1.5 liters up to standard target volumes (2.0 to 2.5 liters per exchange).

Long-Term Maintenance and Kinetic Re-assessment

At 4 to 8 weeks post-initiation, a formal PET and baseline adequacy study (total clearance Kt/V) are performed. Follow-up visits occur monthly to assess fluid status, blood pressure, nutritional indices, exit-site appearance, and blood chemistry parameters.

Indications and Conditions Addressed

Peritoneal dialysis is clinically indicated for the management of severe kidney failure and related metabolic derangements. Specific conditions and clinical scenarios include:

• End-Stage Renal Disease (ESRD / CKD Stage 5): Indicated when glomerular filtration rate (eGFR) falls below 10–15 mL/min/1.73m² with clinical symptoms of uremia, uncontrolled fluid overload, or hyperkalemia (KDIGO 2024 guidelines).
• Cardiorenal Syndrome with Refractory Fluid Overload: Used as a fluid removal strategy in severe heart failure unresponsive to high-dose diuretic therapy.
• Acute Kidney Injury (AKI): Utilized in select clinical settings or resource-limited environments where hemodialysis access is unavailable or hemodynamically destabilizing.
• Pediatric End-Stage Kidney Disease: Preferred early modality in pediatric nephrology to maintain school attendance, normal activity, and preserve vascular access.
• Severe Vascular Access Compromise: Indicated for adult patients with exhausted upper extremity arteriovenous fistula or graft options for hemodialysis.

Pre-treatment preparation for peritoneal dialysis requires comprehensive clinical, surgical, and logistical steps. Patients undergo baseline blood evaluations including renal panel, liver function, complete blood count, coagulation tests, and viral screening. Cardiopulmonary clearance and an abdominal wall examination are conducted to screen for pre-existing hernias or surgical scars.

Surgical preparation involves placing a peritoneal catheter, typically performed laparoscopically by a surgeon or fluoroscopically by an interventional nephrologist. Patients must complete bowel preparation protocols prior to catheter placement to clear the colon, lowering accidental bowel perforation risk and optimizing catheter positioning.

Home environment preparation includes establishing a clean, dry, dedicated space for performing fluid exchanges and storing dialysis supplies. Supplies must be stored off the floor in a clean environment free of pets and drafts. Patients complete mandatory practical training on hand hygiene, mask-wearing during connections, and sterile touch-free techniques before initiating unmonitored home therapy.

Peritoneal dialysis is associated with specific infectious, mechanical, and metabolic risks that require diligent monitoring and adherence to clinical protocols.

Infectious Risks:
- Peritonitis: Infection of the peritoneal membrane, presenting with cloudy effluent fluid, abdominal pain, fever, and elevated white blood cell counts in dialysate (>100 WBC/mcL with >50% neutrophils). Peritonitis is the leading cause of technique failure and transition to hemodialysis (ISPD 2022 guidelines).
- Exit-Site and Tunnel Infection: Redness, purulent discharge, swelling, or pain along the subcutaneous catheter tract, usually caused by Staphylococcus aureus or Pseudomonas species.

Mechanical Complications:
- Pericatheter Leakage: Dialysate fluid leaking around the catheter exit site or into subcutaneous tissues, often caused by early use before complete tissue healing or elevated intra-abdominal pressure.
- Catheter Malfunction or Dislocation: Migration of the catheter tip out of the pelvis, omental wrapping, or fibrin obstruction leading to slow drain times or incomplete fluid removal.
- Abdominal Wall Hernias: Elevated intra-abdominal fluid pressure increases the risk of umbilical, inguinal, or incisional hernias.
- Hydrothorax: Rare flow of dialysate into the pleural space through small diaphragmatic defects, causing acute shortness of breath.

Metabolic and Long-Term Risks:
- Hyperglycemia and Weight Gain: Absorption of dextrose from dialysate can worsen blood sugar control in diabetic patients and contribute to hypertriglyceridemia and weight gain.
- Membrane Failure / Encapsulating Peritoneal Sclerosis (EPS): Prolonged exposure to non-physiologic dialysate over years can cause peritoneal membrane sclerosis, loss of ultrafiltration capacity, or EPS, a rare but serious condition marked by bowel encapsulation and obstruction.

Clinical Patient Journey for Peritoneal Dialysis

Phase 1: Candidate Evaluation & Clinical Workup

Patients with advanced chronic kidney disease (CKD Stage 5) undergo nephrology evaluation, peritoneal membrane mapping, assessment of abdominal surgical history, physical capacity evaluation, and home environment safety checks.

Phase 2: Surgical Catheter Insertion

A specialized silicone catheter (typically a double-cuff Tenckhoff catheter) is placed into the lower peritoneal cavity via minimally invasive laparoscopic or fluoroscopic technique. The catheter is tunnelled under the skin with an exit site created on the lower abdomen.

Phase 3: Catheter Healing & Protocol Training

A healing period of 2 to 4 weeks is maintained to allow the subcutaneous tunnel and tissue cuffs to heal, reducing fluid leak risk. During this period, the patient completes a 1-to-2 week hands-on training protocol covering aseptic technique, exchange mechanics, cycler operation, and infection prevention.

Phase 4: Maintenance Therapy & Dialysis Prescription

Regular daily exchanges commence using CAPD or APD protocols based on peritoneal equilibration test (PET) results. Patients perform daily weight, blood pressure, and ultrafiltration logging at home.

Phase 5: Ongoing Monitoring & Longitudinal Care

Monthly to quarterly clinic evaluations include adequacy testing (total fractional urea clearance or Kt/V), peritoneal transport characterization, exit-site inspections, nutritional labs, and adjusting solution concentrations (dextrose or icodextrin).